Germany

Biotx.ai

2022 2022 Venture | Winner Winner Science Start-ups (Falling Walls Venture)

Biotx.ai is the first company to go from biobank data all the way to a clinical trial phase 2b. Purely computationally, they found a potential COVID-19 treatment via what they call synthetic clinical trials, without a single wet lab experiment, for a fraction of the cost and time usually needed. In addition to the drug in phase 2b, their talented team also has molecules in several disease areas in pre-clinical and phase 1.

Events with Biotx.ai

Mon | Nov 07, 2022 | 02.00 PM - 04.00 PM Berlin Time

Falling Walls Venture Pitches – Session 3: Health Solutions

Tue | Nov 08, 2022 | 09.00 AM - 06.00 PM Berlin Time

Symposium for Breakthroughs in Life Sciences